CS 1544-0975
Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea
TEL 033-435-4962
bgn4@bifido.com
ContactGet in touch helps us to
understand you better
ADDRESS | 23-16, Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea |
---|---|
TEL | + 82-33-435-4962 |
FAX | + 82-33-435-4963 |
bgn4@bifido.com |
ADDRESS | Room 916, Blue zone,150, Jojeong-daero, Hanam-si, Gyeonggi-do, Republic of Korea |
---|---|
TEL | + 82-31-8027-8941 |
FAX | + 82-31-8027-8946 |
bgn4@bifido.com |
ADDRESS | 3rd floor, 639, Seolleung-ro, Gangnam-gu, Seoul, Republic of Korea |
---|---|
TEL | + 82-2-543-5196 |
FAX | + 82-70-7545-0189 |
bgn4@bifido.com |
ADDRESS | Room 1005, Building No.1, No.7001 Zhongchun Road, MinhangDistrict, 201101 Shanghai China |
---|---|
TEL | +86-21-54718163 |
bgn4@bifido.com |
Accrued Bioinformatics
Through Decades
공시제목 | 제출일자 |
---|---|
Outcomes of Annual Meeting of Shareholders | 2023-03-23 |
Submission of Audit Report | 2023-03-15 |
Change of CEO | 2023-03-02 |
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) | 2023-02-23 |
Resolutions for Convocation of General Meeting of Shareholders | 2023-02-23 |
Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading) | 2022-12-02 |
(Forewarning) Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading) | 2022-12-01 |
Outcomes of Annual Meeting of Shareholders | 2022-03-22 |
Submission of Audit Report | 2022-03-14 |
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) | 2022-03-04 |
Resolutions for Convocation of General Meeting of Shareholders | 2022-03-04 |
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(요로감염 개선, 예방 또는 치료를 위한 락토바실러스 살리바리우스 HHuMin-U 균주 및 이를 포함하는 조성물) | 2021-12-07 |
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(요로감염 개선, 예방 또는 치료를 위한 락토바실러스 헬베티쿠스 GUT10 균주 및 이를 포함하는 조성물) | 2021-12-07 |
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(높은 EPS 분비능을 보이는 와이셀라 컨푸사 VP30 및 이로부터 발효된 발효물을 포함하는 변비 개선용 식품 조성물) | 2021-10-06 |
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(비피도박테리움 롱검 RAPO(KTCT13773BP)를 포함하는 암 예방 또는 치료용 조성물) | 2021-09-27 |
Change of The Largest Shareholder | 2021-09-14 |
[Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder | 2021-09-14 |
Change of CEO | 2021-09-14 |
Outcomes of Extraordinary General Meeting of Shareholders | 2021-09-14 |
[Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder | 2021-09-10 |